BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35691796)

  • 1. Loss of stromal cell Thy-1 plays a critical role in lipopolysaccharide induced chronic lung allograft dysfunction.
    Hata A; Guo Y; Miller AE; Hata M; Mei Z; Manafi A; Li D; Banerjee A; Lazear E; Lau C; Gelman AE; Kreisel D; Yoshino I; Wilkes D; Barker TH; Krupnick AS
    J Heart Lung Transplant; 2022 Aug; 41(8):1044-1054. PubMed ID: 35691796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum of chronic lung allograft pathology in a mouse minor-mismatched orthotopic lung transplant model.
    Martinu T; Oishi H; Juvet SC; Cypel M; Liu M; Berry GJ; Hwang DM; Keshavjee S
    Am J Transplant; 2019 Jan; 19(1):247-258. PubMed ID: 30378739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor Batf3 inhibits murine lung allograft rejection and airway fibrosis.
    Watanabe T; Lam C; Oliver J; Oishi H; Teskey G; Beber S; Boonstra K; Mauricio Umaña J; Buhari H; Joe B; Guan Z; Horie M; Keshavjee S; Martinu T; Juvet SC
    Mucosal Immunol; 2023 Apr; 16(2):104-120. PubMed ID: 36842540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A B cell-dependent pathway drives chronic lung allograft rejection after ischemia-reperfusion injury in mice.
    Watanabe T; Martinu T; Chruscinski A; Boonstra K; Joe B; Horie M; Guan Z; Bei KF; Hwang DM; Liu M; Keshavjee S; Juvet SC
    Am J Transplant; 2019 Dec; 19(12):3377-3389. PubMed ID: 31365766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mitigating effect of exogenous carbon monoxide on chronic allograft rejection and fibrosis post-lung transplantation.
    Aoki Y; Walker NM; Misumi K; Mimura T; Vittal R; McLinden AP; Fitzgerald L; Combs MP; Lyu D; Osterholzer JJ; Pinsky DJ; Lama VN
    J Heart Lung Transplant; 2023 Mar; 42(3):317-326. PubMed ID: 36522238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation of Thy-1 gene expression by histone modification is involved in lipopolysaccharide-induced lung fibroblast proliferation.
    He Z; Wang X; Deng Y; Li W; Chen Y; Xing S; Zhao X; Ding J; Gao Y
    J Cell Mol Med; 2013 Jan; 17(1):160-7. PubMed ID: 23305530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrotic progression from acute cellular rejection is dependent on secondary lymphoid organs in a mouse model of chronic lung allograft dysfunction.
    Mineura K; Tanaka S; Goda Y; Terada Y; Yoshizawa A; Umemura K; Sato A; Yamada Y; Yutaka Y; Ohsumi A; Nakajima D; Hamaji M; Mennju T; Kreisel D; Date H
    Am J Transplant; 2024 Jun; 24(6):944-953. PubMed ID: 38403187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptive and innate immune responses in a rat orthotopic lung transplant model of chronic lung allograft dysfunction.
    Evers A; Atanasova S; Fuchs-Moll G; Petri K; Wilker S; Zakrzewicz A; Hirschburger M; Padberg W; Grau V
    Transpl Int; 2015 Jan; 28(1):95-107. PubMed ID: 25179205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor IL-17 receptor A regulates LPS-potentiated acute and chronic murine lung allograft rejection.
    Watanabe T; Juvet SC; Berra G; Havlin J; Zhong W; Boonstra K; Daigneault T; Horie M; Konoeda C; Teskey G; Guan Z; Hwang DM; Liu M; Keshavjee S; Martinu T
    JCI Insight; 2023 Nov; 8(21):. PubMed ID: 37937643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipopolysaccharide promotes pulmonary fibrosis in acute respiratory distress syndrome (ARDS) via lincRNA-p21 induced inhibition of Thy-1 expression.
    Zhou WQ; Wang P; Shao QP; Wang J
    Mol Cell Biochem; 2016 Aug; 419(1-2):19-28. PubMed ID: 27392907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of Humoral Immunity during the Pathogenesis of Experimental Chronic Lung Allograft Dysfunction.
    Reichert M; Atanasova S; Petri K; Kampschulte M; Kojonazarov B; Fuchs-Moll G; Krombach GA; Padberg W; Grau V
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel model for dissecting roles of IL-17 in lung transplantation.
    Chen R; Liang F; Chen Q; Xu J; Ding Y
    J Thorac Dis; 2018 Jun; 10(6):3298-3307. PubMed ID: 30069326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential of biomarkers of fibrosis in chronic lung allograft dysfunction.
    van der Ploeg EA; Melgert BN; Burgess JK; Gan CT
    Transplant Rev (Orlando); 2021 Jul; 35(3):100626. PubMed ID: 33992914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of recipient derived interleukin-17A in a murine orthotopic lung transplant model of restrictive chronic lung allograft dysfunction.
    Yamada Y; Vandermeulen E; Heigl T; Somers J; Vaneylen A; Verleden SE; Bellon H; De Vleeschauwer S; Verbeken EK; Van Raemdonck DE; Vos R; Verleden GM; Jungraithmayr W; Vanaudenaerde BM
    Transpl Immunol; 2016 Nov; 39():10-17. PubMed ID: 27737799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral immune responses mediate the development of a restrictive phenotype of chronic lung allograft dysfunction.
    Misumi K; Wheeler DS; Aoki Y; Combs MP; Braeuer RR; Higashikubo R; Li W; Kreisel D; Vittal R; Myers J; Lagstein A; Walker NM; Farver CF; Lama VN
    JCI Insight; 2020 Dec; 5(23):. PubMed ID: 33268593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Toll-like Receptor 4 Expressed by Fibroblasts in Allograft Fibrosis in Mouse Orthotopic Tracheal Transplantation.
    Kawashima M; Sato M; Murakawa T; Anraku M; Konoeda C; Hosoi A; Kakimi K; Nakajima J
    Transplant Proc; 2018 Dec; 50(10):3863-3872. PubMed ID: 30577279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Halofuginone treatment reduces interleukin-17A and ameliorates features of chronic lung allograft dysfunction in a mouse orthotopic lung transplant model.
    Oishi H; Martinu T; Sato M; Matsuda Y; Hirayama S; Juvet SC; Guan Z; Saito T; Cypel M; Hwang DM; Keller TL; Whitman MR; Liu M; Keshavjee S
    J Heart Lung Transplant; 2016 Apr; 35(4):518-27. PubMed ID: 26787621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of fibroblast Thy-1 expression correlates with lung fibrogenesis.
    Hagood JS; Prabhakaran P; Kumbla P; Salazar L; MacEwen MW; Barker TH; Ortiz LA; Schoeb T; Siegal GP; Alexander CB; Pardo A; Selman M
    Am J Pathol; 2005 Aug; 167(2):365-79. PubMed ID: 16049324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD26 as a target against fibrous formation in chronic airway rejection lesions.
    Jungraithmayr W; Yamada Y; Haberecker M; Breuer E; Schuurmans M; Dubs L; Itani S; Janker F; Weder W; Schmitt-Opitz I; Jang JH
    Life Sci; 2021 Aug; 278():119496. PubMed ID: 33894269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroproliferation in chronic lung allograft dysfunction: Association of mesenchymal cells in bronchoalveolar lavage with phenotypes and survival.
    Combs MP; Xia M; Wheeler DS; Belloli EA; Walker NM; Braeuer RR; Lyu DM; Murray S; Lama VN
    J Heart Lung Transplant; 2020 Aug; 39(8):815-823. PubMed ID: 32360292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.